Morphea after SARS-CoV2 vaccine
An Bras Dermatol
.
2023 May-Jun;98(3):396-398.
doi: 10.1016/j.abd.2022.04.010.
Epub 2023 Feb 6.
Authors
Giovanni Paolino
1
,
Matteo Riccardo Di Nicola
2
,
Nathalie Rizzo
3
,
Santo Raffaele Mercuri
1
Affiliations
1
Unit of Dermatology and Cosmetology, IRCCS San Raffaele Hospital, Milano, Italy.
2
Unit of Dermatology and Cosmetology, IRCCS San Raffaele Hospital, Milano, Italy. Electronic address: dinicola.matteo@hsr.it.
3
Surgical Pathology, IRCCS San Raffaele Hospital, Milano, Italy.
PMID:
36754652
PMCID:
PMC9901267
DOI:
10.1016/j.abd.2022.04.010
No abstract available
Publication types
Case Reports
MeSH terms
COVID-19* / prevention & control
Humans
RNA, Viral
SARS-CoV-2
Scleroderma, Localized* / etiology
Substances
RNA, Viral